in view of the results observed in the dog , where increases in central latencies of somatosensory evoked potentials were clearly apparent , these data provide strong reassurance about the neurological safety of vigabatrin in the treatment of epileptic patients .
C0048044
vigabatrin
C0014544
epileptic